Cargando…

A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1

Detalles Bibliográficos
Autores principales:	Yu, Haisheng, Guo, Pengle, Yang, Yingyin, Dai, Jun, Tang, Xiaoping, Li, Linghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508509/ https://www.ncbi.nlm.nih.gov/pubmed/37592413 http://dx.doi.org/10.1097/CM9.0000000000002810

Ejemplares similares

Three-dose vaccination elicits neutralising antibodies against omicron
por: Wu, Mary, et al.
Publicado: (2022)

Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV
por: Marchitto, Lorie, et al.
Publicado: (2023)

Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV
por: Zou, Shi, et al.
Publicado: (2022)

Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV
por: Lv, Zhengchao, et al.
Publicado: (2022)

Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine
por: Peng, Pai, et al.
Publicado: (2021)

Humoral Immune Response to Inactivated COVID-19 Vaccination at the 3rd Month among People Living with HIV
por: Wu, Songjie, et al.
Publicado: (2022)

Humoral immune response to inactivated COVID-19 vaccination at the 3rd month among people living with HIV
por: Wu, Songjie, et al.
Publicado: (2023)

Advances in diagnosis and treatment of talaromycosis in patients with AIDS
por: Guo, Pengle, et al.
Publicado: (2022)

A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV
por: Lv, Zhengchao, et al.
Publicado: (2023)

A tale of two conditions: when people living with HIV meet three doses of inactivated COVID-19 vaccines
por: Tan, Yuting, et al.
Publicado: (2023)

Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2
por: Ukey, Rahul, et al.
Publicado: (2022)

Antibody response to SARS-CoV-2 in people living with HIV
por: Yamamoto, Shinya, et al.
Publicado: (2021)

Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients
por: Khan, Qamar J., et al.
Publicado: (2022)

Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies
por: Cheng, Lin, et al.
Publicado: (2021)

Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice
por: Barroso, Shana P. C., et al.
Publicado: (2015)

Drug resistance mutations among people living with HIV with treatment failure in Henan Province, China
por: Liu, Jinjin, et al.
Publicado: (2023)

Humoral immune response to COVID-19 vaccines in people with secondary progressive multiple sclerosis treated with siponimod
por: Krbot Skorić, Magdalena, et al.
Publicado: (2022)

The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)
por: Woldemeskel, Bezawit A, et al.
Publicado: (2021)

Development of a nursing intervention to facilitate optimal antiretroviral-treatment taking among people living with HIV
por: Ramirez-Garcia, Pilar, et al.
Publicado: (2009)

Antiretroviral therapy-naïve people living with HIV tend to have more severe symptoms of COVID-19
por: Sun, Jinfeng, et al.
Publicado: (2023)

Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong
por: Chan, Denise Pui Chung, et al.
Publicado: (2022)

Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease”
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023)

Humoral response to SARS-CoV-2 vaccines in people living with HIV
por: Noe, Sebastian, et al.
Publicado: (2021)

Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people
por: Rouco, Santiago Oviedo, et al.
Publicado: (2022)

Why some people tolerate the second dose of a vaccine but not the first dose
por: Yu, Yihua Bruce, et al.
Publicado: (2022)

Dynamics of humoral and T-cell immunity after three BNT162b2 vaccinations in adults older than 80 years
por: Romero-Olmedo, Addi J, et al.
Publicado: (2022)

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
por: Cao, Yunlong, et al.
Publicado: (2021)

Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
por: Prendecki, Maria, et al.
Publicado: (2021)

A third dose of COVID‐19 mRNA vaccine induces limited humoral response in stem cell transplant recipients who got two vaccine doses before transplant
por: Toya, Takashi, et al.
Publicado: (2022)

Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity
por: Westcott, Peter M. K., et al.
Publicado: (2023)

Long-term and effective neutralization against omicron sublineages elicited by four platform COVID-19 vaccines as a booster dose
por: Zhang, Yuemiao, et al.
Publicado: (2023)

Positional weight matrices have sufficient prediction power for analysis of noncoding variants
por: Boytsov, Alexandr, et al.
Publicado: (2022)

Humoral response after the booster dose of anti-SARS-CoV-2 vaccine in multiple sclerosis patients treated with high-efficacy therapies
por: Maglione, Alessandro, et al.
Publicado: (2022)

Neutralisation of ZF2001-elicited antisera to SARS-CoV-2 variants
por: Zhao, Xin, et al.
Publicado: (2021)

Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection
por: Yao, Lin, et al.
Publicado: (2022)

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
por: Alrubayyi, Aljawharah, et al.
Publicado: (2021)

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
por: Alrubayyi, Aljawharah, et al.
Publicado: (2021)

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
por: Alrubayyi, Aljawharah, et al.
Publicado: (2021)

Adherence level to antiretroviral therapy predict the time to viral load suppression of adult people living with HIV on antiretroviral therapy in Arba Minch general hospital
por: Hussen, Sultan, et al.
Publicado: (2019)

Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8t9mt3pj7sqb4sitj7v0mn4ggn